Background To achieve malaria elimination, Brazil must implement Plasmodium vivax
radical cure. We aimed to investigate the operational feasibility of point-of-care, quantitative …

Enhanced therapeutic efficacy achieved in treating Plasmodium vivax malaria with an 8-
aminoquinoline (8-AQ) drug such as primaquine (PQ) together with a partner drug such as …

Abstract Background The Plasmodium vivax merozoite restrictively invades immature
erythrocytes, suggesting that its ligand (s) might interact with corresponding receptor (s) that …

Background Malaria remains a significant cause of morbidity and mortality in Ethiopia with
an estimated 3.8 million cases in 2021 and 61% of the population living in areas at risk of …

Malaria is the deadliest parasitic disease in the world. Traditional control measures have
become less effective; hence, there is a need to explore alternative strategies, such as …

(1) Background: Malaria remains a significant global public health issue. Since parasites
quickly became resistant to most of the available antimalarial drugs, treatment effectiveness …

Plasmodium vivax is the most widespread cause of malaria, especially in subtropical and
temperate regions such as Asia-Pacific and America. P. vivax lactate dehydrogenase …

Plasmodium parasites replicate asexually in human hosts. The proportion of infections that
carries gametocytes is a proxy for human-to-mosquito transmissibility. It is unclear which …

Gametocytes are the forms of the malaria parasite that are essential for the continuation of
the transmission cycle to the vector Anopheles. This study aimed to evaluate the parasite …

Background To interrupt residual malaria transmission and achieve successful elimination of
P. falciparum in low-transmission settings, the World Health Organization (WHO) …